Strengths

Main fields of research

Synaptic transmission and plasticity

Tel Aviv University has the largest number of neuroscientists in Israel investigating the biophysical, molecular and cellular mechanisms of synaptic transmission and plasticity under normal and pathological conditions, as well as in aging, using a broad range of the most advanced technologies. In particular, our molecular and cellular neuroscientists are revealing the link between gene function and brain disorders, a crucial step in the development of novel, more efficient therapies.

Neuroimaging

Neuroimaging is a powerful tool for the direct transferral of discoveries made in the laboratory to the clinic. Tel Aviv University is the leading university in Israel in the development of new approaches and applications in neuroimaging. Tel Aviv University researchers—at both basic and applied levels—are working in affiliation with three imaging centers: the Edersheim-Levi Gitter Center for human brain imaging, the Strauss Center for Computational Neuroimaging’s MRI facility for small animals, and the new Sackler Cellular and Molecular Imaging Center (SCMIC) for cellular and in-vivo imaging. Tel Aviv University is continually improving and innovating structural, functional, molecular and cellular imaging of the brain.

Behavioral and cognitive neuroscience

Tel Aviv University has the strongest record in Israel in behavioral and cognitive neuroscience. While unraveling the mysteries of the brain at the cellular and molecular levels is extremely important for understanding the brain’s machinery, the final question remains: How is this machinery translated into what we ultimately are, namely how we behave, think, remember and feel? Tel Aviv University behavioral and cognitive neuroscientists focus on unraveling brain-behavior relationships under both normal and pathological conditions.

Brain disorders

With more drug candidates for Alzheimer’s disease in the pipeline than virtually any other institution in the world, Tel Aviv University is a leader in the development of novel treatments for Alzheimer’s, Parkinson’s and other neurological diseases, as well as for psychiatric disorders and brain cancer. Together with leading physicians at affiliated hospitals, Tel Aviv University scientists are targeting the underlying genetics of brain disorders, improving diagnostic methods and moving us ever closer to predictive, preventive and personalized treatment.